Pacific Global Investment Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,508
| Closed | -$239K | – | 222 |
|
|
2021
Q4 | $239K | Sell |
5,508
-4,453
| -45% | -$193K | 0.04% | 200 |
|
|
2021
Q3 | $499K | Sell |
9,961
-391
| -4% | -$19.6K | 0.1% | 136 |
|
|
2021
Q2 | $652K | Sell |
10,352
-210
| -2% | -$13.2K | 0.13% | 123 |
|
|
2021
Q1 | $981K | Sell |
10,562
-454
| -4% | -$42.2K | 0.2% | 97 |
|
|
2020
Q4 | $987K | Sell |
11,016
-196
| -2% | -$17.6K | 0.22% | 99 |
|
|
2020
Q3 | $1.16M | Sell |
11,212
-79
| -0.7% | -$8.17K | 0.3% | 76 |
|
|
2020
Q2 | $893K | Sell |
11,291
-7,349
| -39% | -$581K | 0.25% | 90 |
|
|
2020
Q1 | $1.08M | Buy |
18,640
+9,232
| +98% | +$534K | 0.34% | 76 |
|
|
2019
Q4 | $508K | Buy |
9,408
+2,523
| +37% | +$136K | 0.11% | 144 |
|
|
2019
Q3 | $360K | Buy |
+6,885
| New | +$360K | 0.08% | 159 |
|